Significance of occult gastrointestinal bleeding during anticoagulation therapy

Barry W. Jaffin, C. Michael Bliss, J. Thomas Lamont

Research output: Contribution to journalArticlepeer-review

52 Scopus citations

Abstract

A prospective study was undertaken to determine the effect of anticoagulation therapy on the prevalence of occult gastrointestinal bleeding and to ascertain the causes of bleeding. During a six-month period, 256 patients who had received anticoagulants were screened for occult bleeding with guaiac-impregnated cards. Twenty-one (12 percent) of the 175 patients who had received anticoagulants and who voluntarily completed the cards had occult gastrointestinal bleeding compared with only two (3 percent) of 74 control patients who had not received anticoagulants. The mean prothrombin time and partial thromboplastin time did not differ significantly in the patients who had received anticoagulants with and without subsequent bleeding. Fifteen of 16 patients who had received anticoagulants and who underwent diagnostic evaluation had previously undiagnosed lesions in the intestinal tract. These results indicate that occult gastrointestinal bleeding in a patient who has received an anticoagulant should not be attributed to the anticoagulant; instead, such bleeding often indicates the presence of significant intestinal disease.

Original languageEnglish
Pages (from-to)269-272
Number of pages4
JournalAmerican Journal of Medicine
Volume83
Issue number2
DOIs
StatePublished - Aug 1987
Externally publishedYes

Fingerprint

Dive into the research topics of 'Significance of occult gastrointestinal bleeding during anticoagulation therapy'. Together they form a unique fingerprint.

Cite this